For more than a century, clinical investigators¹ have focused on early life as a source of adult psychopathology（精神病理学） . Although the hypothesized（假定，假设） mechanisms² have evolved, a central notion remains³: early life is a period of unique sensitivity during which experience confers（授予，给予） enduring effects. Neurodevelopmental disorders⁴, which include mood disorders, schizophrenia（精神分裂症） , autism（孤独症） and eating disorders, have been associated with fetal antecedents such as maternal⁵（母亲的，母性的） stress or infection and malnutrition⁶. Sex is another factor that influences the risk for psychiatric disorders through poorly understood mechanisms.

We know little as to how the maternal environment alters offspring programming. Epigenetics（实验胚胎学） , an area of research that is studying how environmental factors produce lasting⁸ changes in gene⁷ expression without altering DNA⁹ sequence, may provide new insights into this question.

A new review, published in Biological Psychiatry¹⁰, has "incorporated the latest insight gained from clinical and epidemiological（流行病学的） studies with potential epigenetic（后生的，外成的） mechanisms from basic research," explained first author Dr. Tracy Bale. These key findings are from a conference on Early Life Programming and Neurodevelopmental Disorders held at the University of Pennsylvania.

For example, the authors discuss findings where maternal stress has been associated with an increased risk of schizophrenia in male offspring and may alter fetal brain growth. Data also indicate that maternal stress, infection, and/or exposure to famine contribute to an elevated risk for depression in offspring. Of critical importance, the brain continues to develop into adolescence¹¹, and so later influences, such as exposure to child abuse and/or neglect, must also be taken into account. Studies have consistently shown that adults who experience maltreatment as children are at a much greater risk of developing mood disorders.

Clearly, multiple factors are at play that influence an individual's disease risk. By applying the principals of personalized medication, one can view this science as "personalized prevention," as it aims to apply these principals earlier in the pathological（病理学的） process. Understanding and defining these disease mechanisms at the very earliest points in life could help identify novel targets in therapy and prevention.